Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2016. Start Trial.
Date Value
June 30, 2026 -14.59M
March 31, 2026 -15.82M
December 31, 2025 -10.96M
September 30, 2025 -3.977M
June 30, 2025 -11.04M
March 31, 2025 -17.71M
December 31, 2024 -2.008M
September 30, 2024 -6.914M
June 30, 2024 51.02M
March 31, 2024 -23.80M
December 31, 2023 39.34M
September 30, 2023 -17.48M
June 30, 2023 -19.47M
March 31, 2023 -28.61M
December 31, 2022 -1.824M
September 30, 2022 -26.54M
June 30, 2022 -24.43M
March 31, 2022 -37.23M
December 31, 2021 -21.88M
September 30, 2021 -36.06M
June 30, 2021 -17.58M
Date Value
March 31, 2021 -49.14M
December 31, 2020 -51.88M
September 30, 2020 -31.94M
June 30, 2020 -36.20M
March 31, 2020 -6.497M
December 31, 2019 -5.532M
September 30, 2019 -28.12M
June 30, 2019 -24.24M
March 31, 2019 -24.21M
December 31, 2018 -22.90M
September 30, 2018 -16.24M
June 30, 2018 -13.10M
March 31, 2018 -20.61M
December 31, 2017 -9.986M
September 30, 2017 -16.31M
June 30, 2017 -10.76M
March 31, 2017 -17.93M
December 31, 2016 5.894M
September 30, 2016 -9.590M
June 30, 2016 -13.84M
March 31, 2016 -29.19M

Free Cash Flow Definition

Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

View Free Cash Flow (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow (Quarterly) Benchmarks

View Free Cash Flow (Quarterly) Benchmarks
Start Trial
DBV Technologies SA -49.68M
Akari Therapeutics Plc -3.112M
EDAP TMS SA -4.949M
Bicycle Therapeutics Plc -49.96M
argenx SE --